23.09.2016 Views

Future of an Ageing Population

gs-16-10-future-of-an-ageing-population

gs-16-10-future-of-an-ageing-population

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

6.4 Medical <strong>an</strong>d assistive technologies<br />

Technology is likely to play <strong>an</strong> increasingly import<strong>an</strong>t role in providing health <strong>an</strong>d<br />

care support, <strong>an</strong>d in connecting people. This may include the mainstreaming<br />

<strong>of</strong> technology-enabled care services, for example home health monitoring<br />

tools, the use <strong>of</strong> social media to create <strong>an</strong>d sustain online communities with<br />

shared interests <strong>an</strong>d the increasing <strong>an</strong>d more sophisticated use <strong>of</strong> health data<br />

to improve clinical treatments 177 .<br />

The rapid evolution <strong>of</strong> medical <strong>an</strong>d assistive technologies makes predicting the<br />

scale <strong>of</strong> their impact difficult 186 . The speed <strong>of</strong> development also creates a need<br />

for new methods <strong>of</strong> evaluation <strong>of</strong> these technologies 177 . While technologies<br />

that assist in health <strong>an</strong>d care could be signific<strong>an</strong>t contributors to the growth in<br />

expenditures in these sectors in the short term, they could potentially reduce<br />

costs signific<strong>an</strong>tly in the medium <strong>an</strong>d long-terms. These savings will depend<br />

on the type <strong>of</strong> technology, for example whether they treat symptoms, prevent<br />

disease, ch<strong>an</strong>ge behaviour, radically innovate or incrementally improve, <strong>an</strong>d<br />

how they are implemented 187,188 .<br />

Developments such as 3D-printed joints <strong>an</strong>d org<strong>an</strong>s, therapeutic robotics<br />

<strong>an</strong>d genomics have great potential to improve health outcomes across the<br />

population 189 , while improvements in personalised (‘precision’) <strong>an</strong>d stratified<br />

medicine may allow better targeting <strong>of</strong> medicines, making treatments more<br />

cost-effective 190 . Increases in real-time data collection, driven by developments<br />

in wearable technology <strong>an</strong>d other forms <strong>of</strong> telemonitoring, will enable<br />

healthcare pr<strong>of</strong>essionals to provide more appropriate treatment <strong>an</strong>d support<br />

for patients <strong>an</strong>d carers 191 while the resulting large datasets could drive forward<br />

research in m<strong>an</strong>y areas <strong>an</strong>d potentially help improve prevention <strong>an</strong>d early<br />

intervention 177 . Technology such as alarms, home monitoring systems <strong>an</strong>d<br />

GPS locators c<strong>an</strong> help carers locate people with dementia, although ethical<br />

issues c<strong>an</strong> arise. There is evidence that carers are already using <strong>of</strong>f the shelf<br />

technologies such as baby monitors <strong>an</strong>d smartphone-based GPS tracking apps<br />

in supporting people living with dementia 192 , but specialised technology could<br />

be more widely <strong>an</strong>d effectively used.<br />

To capitalise on the adv<strong>an</strong>ces in assistive technology, a number <strong>of</strong> barriers will<br />

need to be overcome, those being common to all technologies (see Chapter 7)<br />

<strong>an</strong>d some specific to assistive technologies. As with m<strong>an</strong>y new technologies, cost<br />

c<strong>an</strong> be a barrier to their implementation. The use <strong>of</strong> telecare to improve social<br />

<strong>an</strong>d health care for vulnerable older people was judged not yet cost-effective<br />

when assessed 193,194 , <strong>an</strong>d the commissioning <strong>of</strong> technology could be inhibited<br />

because the public service provider might not benefit directly from the potential<br />

savings 195 . Local authorities could fund care-assisting technologies but the NHS<br />

would gain benefits through, for example, reductions in hospital admissions.<br />

P85

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!